Introduction: Heart failure (HF) is a leading cause of hospitalization worldwide, with high mortality rates and significant economic burden. To address the issue outpatient strategies (day-care diuretics) to avoid unplanned ED visits and reduce HF hospitalizations. However, the identification of low risk patients worsening heart failure (WHF) who could benefit from outpatient treatment remains poorly documented.

Objective: We aimed to evaluate the accuracy of multiple scores in predicting the risk of 30-day events in patients WHF who underwent brief hospitalizations.

Methods: We conducted a retrospective analysis of a prospective and consecutive cohort of WHF patients with hospitalizations of less than 72 h at a tertiary care hospital between 2015 and 2020. The risk of 30-day all-cause mortality was evaluated using the OPTIMIZE-HF, GWTG-HF, and ADHERE risk scores. And the secondary endpoint was the combined unplanned visit or readmission for worsening HF or death at 30 days. The risk of events in low-risk populations was analyzed by tertiles within the most predictive model.

Results: Among the 200 included patients (mean age: 75.5 ± 12 years; 62% male), 95.9% had a 30-day follow-up, with an overall mortality rate of 4% and a secondary composite endpoint of 14%. AUC-ROC for the prediction of 30-day all-cause mortality were 0.76 (95% CI 0.59-0.93), 0.66 (95% CI 0.46-0.86), and 0.64 (95% CI 0.44-0.85) for OPTIMIZE-HF, GWTG-HF, and ADHERE, respectively. For the secondary combined event, the AUC-ROC was 0.70 (95% CI 0.59-0.79) for OPTIMIZE-HF, GWTG-HF 0.67 (0.56-0.77) and ADHERE 0.67 (0.56 -0.77). The three scores had good calibration (Hosmer-Lemeshow goodness-of-fit test >0.05). Among the low-risk patients (n = 76, OPTIMIZE-HF score <32), the incidence of mortality and combined events at 30 days was 1.3% and 5.3%, respectively. Kaplan-Meier survival analysis showed that low risk patients had lower risk of the combined event (log rank p < 0.006).

Conclusion: Among WHF patients with short hospital stays, the OPTIMIZE-HF score exhibited superior predictive ability compared to other scores and may serve as a valuable tool for assessing the risk of death or combined events at 30 days. Utilizing the OPTIMIZE-HF risk score could aid in identifying low-risk patients who might benefit from outpatient management of AHF in a day-care diuretic clinic.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cpcardiol.2025.103023DOI Listing

Publication Analysis

Top Keywords

heart failure
12
optimize-hf gwtg-hf
12
low-risk patients
8
patients worsening
8
worsening heart
8
risk scores
8
scores predicting
8
risk events
8
risk 30-day
8
30-day all-cause
8

Similar Publications

Importance: Excess body fat plays a pivotal role in the pathogenesis of heart failure with preserved ejection fraction (HFpEF). HU6 is a novel, controlled metabolic accelerator that enhances mitochondrial uncoupling resulting in increased metabolism and fat-specific weight loss.

Objective: To assess efficacy and safety of HU6 in reducing body weight, improving peak volume of oxygen consumption (VO2) and body composition among patients with obesity-related HFpEF.

View Article and Find Full Text PDF

Importance: Food insecurity is associated with prevalent cardiovascular disease (CVD), but studies have been limited to cross-sectional data.

Objectives: To study whether food insecurity is associated with incident CVD and to determine whether this association varies by sex, education, or race.

Design, Setting, And Participants: This prospective cohort study was conducted among US adults without preexisting CVD participating in the CARDIA (Coronary Artery Risk Development in Young Adults) study from 2000 to August 31, 2020.

View Article and Find Full Text PDF

Context: Simulation-based medical education (SBME) is a method for enhancing learner skill prior to initiating care for real patients. Although the use of SBME continues to grow, there is limited data on simulations related to osteopathic medical training. Osteopathic manipulative medicine (OMM) applies hands-on techniques to facilitate healing.

View Article and Find Full Text PDF

Danshensu Derivatives: A Series of Promising Drugs With Protective Effects Against Cardiocerebrovascular Diseases and Cancers.

Med Res Rev

March 2025

Xi'an Key Laboratory of Innovative Drug Research for Heart Failure, Faculty of Life Sciences and Medicine, Northwest University, Xi'an, China.

Salvia miltiorrhiza (Danshen in Chinese) is a traditional medicinal plant with an extensive range of cardiocerebrovascular protective effects widely used in China and other Asian countries. Danshensu (DSS) is the most important water-soluble component of Danshen and has significant antioxidant, anti-inflammatory, antiplatelet aggregation, antitumor, and other pharmacological activities. However, DSS has poor fat solubility and is unstable due to its o-phenol hydroxyl and α-hydroxy carboxylic acids.

View Article and Find Full Text PDF

Introduction: Various ventricular repolarization parameters are known to predict ventricular arrhythmias and mortality in various diseases. Although mortality in patients with heart failure with preserved ejection fraction (HFpEF) is similar to that in heart failure with reduced ejection fraction patients, studies on this subject are more limited. Therefore, it is important to evaluate the relationship between ventricular arrhythmias and mortality and ventricular repolarization parameters, especially the frontal plane QRS-T angle, in patients with HFpEF.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!